Notably, APOE ε4 homozygosity has been recently proposed as another form of genetically determined AD, owing to near-full penetrance, the predictability of symptom onset, and a probable sequence of biomarker and clinical changes [51]. This evidence concerns the gene APOE and Alzheimer disease.